Evidence map›Paper›PMID 40082379›Full record

ReviewThe protein journal2025

Research Progress on Douchi Fibrinolytic Enzyme.

Mengxue Cheng, Panpan Wang, Mei Li, Cuiying Peng, Xuhui Fang, Zhilang Deng, Xiongwei Deng, Xiaomei Xie, Meizhi Weng

Abstract readReview
PubMed Publisher
In one paragraph

Review in The protein journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengxue ChengJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China.
Panpan WangJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China.
Mei LiJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China.
Cuiying PengJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China.
Xuhui FangJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China.
Zhilang DengJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China.
Xiongwei DengNanchang Hongdu Hospital of TCM, Affiliated to Jiangxi University of Chinese Medicine, Nanchang, 330008, Jiangxi, People's Republic of China. dengxiongwei1130@163.com.
Xiaomei XieJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China. jxxm1964@sina.com.
Meizhi WengJiangxi University of Chinese Medicine, Nanchang, 330004, Jiangxi, People's Republic of China. meizhiweng@whu.edu.cn.

Funding

First level discipline of integrated traditional Chinese and Western medicine at Jiangxi University of Chinese Medicine double first-class disciplines in Jiangxi Province, zxyylxk20220103Innovation and Entrepreneurship Project 202410412045Innovation and Entrepreneurship Project 202410412294Innovation and Entrepreneurship Project JZYC23S03Innovation and Entrepreneurship Project XJ-S202417National Natural Science Foundation of China Projec 82060699National Natural Science Foundation of China Projec 82360772Project of Jiangxi Natural Science Foundation 20192ACBL21032Project of Jiangxi Natural Science Foundation 20192BAB205098Project of Jiangxi Natural Science Foundation 20224BAB206103Project of Jiangxi Natural Science Foundation 20232BAB206161Project of Jiangxi Natural Science Foundation 20242BAB26173
6 · The paper itself

Abstract

In recent years, the morbidity and mortality owing to thrombotic diseases have increased. Fibrinolytic enzymes can dissolve thrombosis. Existing thrombolytic drugs are expensive, have short half-lives, and cause bleeding easily. Consequently, there is a need to develop safe, effective, and inexpensive thrombolytic drugs. The Douchi fibrinolytic enzyme (DFE), a serine protease that can dissolve fibrous proteins from the traditional fermented food Douchi, has been isolated recently. DFE is non-toxic and free from side effects like bleeding. In addition, it has a low molecular weight, owing to which it can be absorbed directly through the digestive tract or taken orally, thereby attracting increasing attention. In this review, first, we introduce the commonly used methods for determining DFE activity. Second, we summarize the strains of DFE-producing bacteria, optimization of the fermentation process, mutation breeding, and recombinant expression. Finally, we discuss the isolation and purification procedures, physicochemical properties, and in vitro and in vivo thrombolytic effects of DFE. Thus, we demonstrate that the extraction of DFE from Douchi, a traditional Chinese fermented food, has considerable potential for development.

Indexed as

Fermented FoodsFibrinolytic AgentsSerine ProteasesThrombosisAnimalsHumansFibrinolytic AgentsSerine ProteasesCardiovascular diseasesDouchi fibrinolytic enzymeFermentation processMutagenesis breedingSeparation and purificationThrombolytic

Identifiers

PMID40082379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.